Samaritan Contracts With Sebiopharm

Samaritan Pharmaceuticals a developer of innovative drugs announced it has contracted with Sebiopharm, Paris, France, to perform preclinical pharmacokinetic studies with its lead compounds. Pharmacokinetic studies are designed to yield information as to the extent and duration of systemic exposure of a drug on the human body.

()a href="http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20050602005281&newsLang=en" target="_blank">Business Wire